MassMutual Private Wealth & Trust’s Lifecore Biomedical LFCR Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.3K	Hold	1,966	–	–	﹤0.01%	1399
2026 Q1	$7.31K	Sell	1,966 -1,473	-43%	-$10.2K	﹤0.01%	1511
2025 Q4	$28.1K	Hold	3,439	–	–	﹤0.01%	986
2025 Q3	$25.3K	Sell	3,439 -549	-14%	-$4.15K	﹤0.01%	1019
2025 Q2	$32.4K	Sell	3,988 -699	-15%	-$4.71K	﹤0.01%	923
2025 Q1	$33K	Sell	4,687 -23,413	-83%	-$146K	﹤0.01%	853
2024 Q4	$209K	Buy	+28,100	New	+$180K	0.01%	443
2023 Q2	–	Sell	-51	Closed	-$193	–	1971
2023 Q1	$193	Buy	+51	New	+$284	﹤0.01%	1768

Other funds holding LFCR

CWC Advisors Lake Oswego, Oregon $225M AUM 23.94% 1-Year Est. Return

DBA Trading Fort Lauderdale, Florida $199M AUM

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

MAA

Mraz Amerine & Associates Modesto, California $697M AUM 19.37% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

UIA

Ulland Investment Advisors Minneapolis, Minnesota $136M AUM 32.68% 1-Year Est. Return

MassMutual Private Wealth & Trust's LFCR Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Lifecore Biomedical (LFCR) position steady in Q2 2026 at 1,966 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1399.

MassMutual Private Wealth & Trust first reported a position in LFCR in Q1 2023 and has held it in 8 quarters since. The position peaked at $209K in Q4 2024. 17 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

MassMutual Private Wealth & Trust held 1,966 shares of Lifecore Biomedical worth $10.3K as of Q2 2026.
MassMutual Private Wealth & Trust left its Lifecore Biomedical share count unchanged in Q2 2026.
Lifecore Biomedical made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1399 holding.
MassMutual Private Wealth & Trust first reported a position in Lifecore Biomedical in Q1 2023 and has held it in 8 quarters since.
MassMutual Private Wealth & Trust's Lifecore Biomedical position peaked at $209K in Q4 2024.
17 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.